Associations of polymorphism of P22phox C242T, plasma levels of vitamin E, and smoking with coronary heart disease in China

American Heart Journal

Volumn 153, Issue 4, 2007, Pages 640.e1-640.e6

  He, Mei An ^a   Cheng, Long Xian ^b   Jiang, Chang Zheng ^a   Zeng, He Song ^c   Wang, Jing ^a   Wang, Feng ^a   Chen, Ying ^b   Yang, Miao ^a   Tan, Hao ^a   Zheng, Hong Yan ^a   Hu, Frank B ^d   Wu, Tang Chun ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b UNION HOSPITAL   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; PROTEIN P22;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHINA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SMOKING;

EID: 33947317317     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.01.002     Document Type: Article

References (34)

1. Traber M.G., Winklhofer-Roob B.M., Roob J.M., et al. Vitamin E kinetics in smokers and nonsmokers. Free Radic Biol Med 31 (2001) 1368-1374
2. Weinberg R.B., VanderWerken B.S., Anderson R.A., et al. Pro-oxidant effect of vitamin E in cigarette smokers consuming a high polyunsaturated fat diet. Arterioscler Thromb Vasc Biol 21 (2001) 1029-1033
3. Alberg A. The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients. Toxicology 180 (2002) 121-137
4. Church D.F., and Pryor W.A. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64 (1985) 111-126
5. Brude I.R., Drevon C.A., Hjermann I., et al. Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants. Arterioscler Thromb Vasc Biol 17 (1997) 2576-2588
6. Mugge A. The role of reactive oxygen species in atherosclerosis. Z Kardiol 87 (1998) 851-864
7. Kunsch C., and Medford R.M. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85 (1999) 753-766
8. Steinberg D. At last, direct evidence that lipoxygenases play a role in atherogenesis. J Clin Invest 103 (1999) 1487-1488
9. Diaz M.N., Frei B., Vita J.A., et al. Antioxidants and atherosclerotic heart disease. N Engl J Med 337 (1997) 408-416
10. Griendling K.K., Minieri C.A., Ollerenshaw J.D., et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74 (1994) 1141-1148
11. phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271 (1996) 23317-23321
12. Dinauer M.C., Pierce E.A., Bruns G.A., et al. Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest 86 (1990) 1729-1737
13. Inoue N., Kawashima S., Kanazawa K., et al. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 97 (1998) 135-137
14. Cahilly C., Ballantyne C.M., Lim D.S., et al. A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res 86 (2000) 391-395
15. Gardemann A., Mages P., Katz N., et al. The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals. Atherosclerosis 145 (1999) 315-323
16. Saha N., Sanghera D.K., and Kamboh M.I. The p22 phox polymorphism C242T is not associated with CHD risk in Asian Indians and Chinese. Eur J Clin Invest 29 (1999) 999-1002
17. Landes N., Pfluger P., Kluth D., et al. Vitamin E activates gene expression via the pregnane X receptor. Biochem Pharmacol 65 (2003) 269-273
18. Bobak M., Brunner E., Miller N.J., et al. Could antioxidants play a role in high rates of coronary heart disease in the Czech Republic?. Eur J Clin Nutr 52 (1998) 632-636
19. Street D.A., Comstock G.W., Salkeld R.M., et al. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction?. Circulation 90 (1994) 1154-1161
20. Grundy S.M., Pasternak R., Greenland P., et al. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 100 (1999) 1481-1492
21. phox C242T polymorphism with nephropathy in type 2 diabetic patients. J Nephrol 18 (2005) 733-738
22. Zhang C., Wang Z., Li D., et al. Simultaneous determination of retinol, cholecalciferol, α-tocopherol, β-carotene in human serum by nonaqueous reversed-phase high performance liquid chromatography. Chin J Chromatogr 13 (1995) 458-459
23. Lundberg M., Fredlund P., Hallqvist J., et al. A SAS program calculating three measures of interaction with confidence intervals. Epidemiology 7 (1996) 655-656
24. Khoury M.J., and James L.M. Population and familial relative risks of disease associated with environmental factors in the presence of gene-environment interaction. Am J Epidemiol 137 (1993) 1241-1250
25. Hayaishi-Okano R., Yamasaki Y., Kajimoto Y., et al. Association of NAD(P)H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes. Diabetes Care 26 (2003) 458-463
26. phox gene variants are associated with systemic oxidative stress biomarker responses to exercise training. J Appl Physiol 99 (2005) 1905-1911
27. phox expression and NADPH oxidase activity in hypertension. Hypertension 44 (2004) 163-169
28. Salonen J.T., Yla-Herttuala S., Yamamoto R., et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339 (1992) 883-887
29. phox in human coronary arteries. Circulation 100 (1999) 1494-1498
30. Warnholtz A., Nickenig G., Schulz E., et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 99 (1999) 2027-2033
31. Schachinger V., Britten M.B., Dimmeler S., et al. NADH/NADPH oxidase p22 phox gene polymorphism is associated with improved coronary endothelial vasodilator function. Eur Heart J 22 (2001) 96-101
32. Shimo-Nakanishi Y., Hasebe T., Suzuki A., et al. Functional effects of NAD(P)H oxidase p22(phox) C242T mutation in human leukocytes and association with thrombotic cerebral infarction. Atherosclerosis 175 (2004) 109-115
33. Wyche K.E., Wang S.S., Griendling K.K., et al. C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension 43 (2004) 1246-1251
34. Kharb S., and Singh G.P. Effect of smoking on lipid profile, lipid peroxidation and antioxidant status in normal subjects and in patients during and after acute myocardial infarction. Clin Chim Acta 302 (2000) 213-219